La. Federal Jury Orders Takeda, Lilly to Pay $9 Billion in Punitive Damages to Actos Plaintiff




LAFAYETTE, La. — At the conclusion of the first Actos federal bellwether trial, a Louisiana federal jury has issued a $9 billion punitive damages verdict against Takeda Pharmaceutical Co. and Eli Lilly & Co., finding the defendants concealed the risk of cancer posed by the diabetes drug Actos.

After deliberating for four hours, the U.S. District Court for the Western District of Louisiana jury determined in the April 7 verdict that Takeda must pay plaintiff Terrence Allen $6 billion in punitive damages and its partner, Lilly, must pay $3 billion. In addition, the jury has awarded Allen $1.475 million in …

FIRM NAMES
  • Adams & Reese
  • Beasley Allen
  • Foliart Huff Ottaway & Bottom
  • Greenberg Traurig
  • Lewis & Roca
  • Neblett Beard & Arsenault
  • Sidley Austin
  • The Lanier Law Firm
  • Tucker Ellis
  • Venable
  • Weitz & Luxenberg





UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Video Game Addiction Product Liability Litigation

March 29, 2024

MORE DETAILS



HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024

MORE DETAILS